Radiotherapy-immunotherapy trials meta-analysis
Authors: Mathijs Tomassen et al.
ImmunoRad Living Meta-Analysis
This page presents a living meta-analysis focused on research exploring the combination of radiotherapy and immunotherapy in cancer treatment. A meta-analysis combines and compares results from multiple scientific studies to provide a broader and more comprehensive understanding of available evidence.
Lay Summary
Cancer treatments are evolving rapidly. Among the approaches being studied, the combination of radiotherapy, which targets tumor cells using radiation, and immunotherapy, which helps the immune system recognize and fight cancer cells, is gaining increasing attention.
This living meta-analysis aims to gather and continuously update scientific data on this topic. It allows researchers, clinicians, and healthcare professionals to follow the evolution of knowledge in a transparent and structured way.
Scientific Background
The ImmunoRad field lies at the intersection of immunology, immunotherapy, and radiotherapy. It explores how radiation can influence the tumor microenvironment and modulate immune responses.
In this context, living meta-analyses are particularly valuable: instead of being fixed at a single point in time, they can be updated as new studies become available.
Authors and Contributors
Project communicated by Mathijs Tomassen.
Full author list, affiliations, and scientific references should be confirmed with the authors prior to publication.
